Abstract Retinal degeneration (RD) in the Miniature Long Haired Dachshund (MLHD) is a cone-rod dystrophy resulting in eventual blindness in affected individuals. In a previous study, a 44-nucleotide insertion (ins44) in exon 2 of RPGRIP1 was associated with RD. However, results on an extended population of MLHD revealed a variable RD onset age for ins44 homozygous dogs. Further investigations using a genome-wide association study comparing early onset and late onset RD cases identified an age of onset modifying locus for RD, approximately 30 Mb upstream of RPGRIP1 on chr15. In this investigation, target enriched sequencing identified a MAP9 deletion spanning approximately 22 kb associated with early RD onset. Identification of the deletion required correction to the CanFam3.1 genome build as canine MAP9 is part of a historic tandem duplication, resulting in incomplete assembly of this genome region. The deletion breakpoints were identified in MAP9 intron 10 and in a downstream partial MAP9 pseudogene. The fusion of these two genes, which we have called MAP9 EORD (microtubule-associated protein, early onset retinal degeneration), is in frame and is expressed at the RNA level, with the 3 0 region containing several predicted deleterious variants. We speculate that MAP9 associates with a-tubulin in the basal body of the cilium. RPGRIP1 is also known to locate to the cilium, where it is closely associated with RPGR. RPGRIP1 mutations also cause redistribution of a-tubulin away from the ciliary region in photoreceptors. Hence, a MAP9 partial deficit is a particularly attractive candidate to synergise with a partial RPGRIP1 deficit to cause a more serious disease.
Introduction
Retinal degeneration (RD) in the Miniature Long Haired Dachshund (MLHD), first described by Curtis and Barnett 1993 and later further clinically characterised by Turney et al. (2007) , is a cone-rod dystrophy where first the cone and then the rod photoreceptors of the retina become depleted resulting in eventual blindness. The disease was first characterised in a colony of MLHD segregating RD in a manner consistent with an autosomal recessive inheritance. Clinical signs included tapetal hyperreflectivity, early cone-specific ERG amplitude reduction and, to a lesser extent, a reduction in rod ERG amplitude. Degeneration progressed fully with no detectable ERG responses after 40 weeks of age in RD affected colony dogs (Turney et al. 2007) .
Genetic analysis of the RD which segregated within a closed breeding colony of MLHD identified a 44-nucleotide insertion (ins44) in exon 2 of the retinitis pigmentosa GTPase regulator-interacting protein 1 (RPGRIP1) gene (Mellersh et al. 2006 ). This variant was predicted to alter the reading frame, causing a frameshift and premature termination. The variant segregated perfectly within the breeding colony, and given the strong association of RPGRIP1 with Leber congenital amaurosis in human populations (Dryja et al. 2001; Gerber et al. 2001 ) and predictions for a truncated protein, the insertion was deemed likely to be the cause of RD for this particular dog breed.
Despite perfect concordance of ins44 with RD in the closed breeding colony, evidence from DNA testing laboratories, breeders and veterinarians indicated that there was considerable phenotype-genotype discordance within MLHDs that were not directly related to the experimental colony as not all dogs that were homozygous for ins44 were developing early onset RD (EORD) but in fact were developing RD at a much later stage or not at all within their lifespan. A study of 59 sporadic cases and 200 apparently normal controls from the MLHD pet dog population revealed 16 % of controls to be homozygous for ins44 and 20 % of cases as non-homozygous for ins44 (Miyadera et al. 2009 ). In an independent study of 23 control MLHD and 34 ins44 homozygotes, it was demonstrated that the ins44 homozygous genotype does not invariably lead to the early cone-rod retinal dystrophy (cord) phenotype (Busse et al. 2011) . Age of RD onset ranges of from 0.3 to 15 years amongst ins44 homozygous dogs in the wider population, and subsequently an age of onset modifying locus was identified for RD in the MLHD using a genome-wide association study approach comparing EORD with late onset RD (LORD) cases, although the modifying variant was not identified (Miyadera et al. 2012b) .
The ins44 mutation has also been identified in the English Springer Spaniel (ESS) and heterozygously in the Labrador Retriever and French bulldog dog breeds. In addition, a slightly longer insert (ins69) was detected at the same position in Beagles (BE), including homozygous individuals (Miyadera et al. 2009) . A small study investigating RD in ESS from the US showed that out of six ins44 homozygous ESS dogs, four showed clinical signs, suggesting that an age of onset modifying locus may also play a role in development of RPGRIP1-associated disease in the ESS (Narfstrom et al. 2012 ). In the same study, investigation of Swedish ESS showed eight out of ten cases of RD in the ESS were not homozygous for the ins44 variant suggesting potential alternative clinical or genetic causes of RD in this breed.
Since the identification of the RPGRIP1 ins44 mutation, experimental data from retinal RNA studies of ins44 dogs have shown that rather than causing an insertion of an aberrant string of codons and a frameshift, the ins44 mutation actually results in an alternative splicing pattern and skipping of exon 2 of RPGRIP1. But despite exon 2 skipping in cRPGRIP1Ins44/Ins44 dogs, the protein pattern detected in Western blots with an antiRPGRIP1 antibody is the same as in cRPGRIP1?/? and cRPGRIP1?/Ins44 retinal samples (Kuznetsova et al. 2012 ). This study proposed exclusion of ins44 as the causal variant for RD and suggested an alternative (as yet unidentified) variant either within RPGRIP1 or within the mapped region as the true cause of RD.
As RPGRIP1 is associated with human Leber congenital amaurosis, RPGRIP1-associated RD in the dog has been considered as a potential model for gene therapy studies since the identification of the ins44 variant (Lheriteau et al. 2009 ). In a recent study using ins44 homozygous dogs derived from the original colony presenting early onset RD cases, gene therapy was reported to have been successfully used to significantly and stably rescue cone function, by subretinal injection of adeno-associated virus (AAV) encoding canine RPGRIP1 (Lheriteau et al. 2014) . These experiments either provide evidence that a mutation in RPGRIP1 or a mutation affecting its expression is causal of RD in the dog, or that overexpression of RPGRIP1 is capable of re-establishing a normal phenotype.
Since its identification, the ins44 insertion has been subject to scientific investigation, discussion and debate. However, regardless of whether the ins44 mutation is the causal mutation for RD in the MLHD, or whether the causal mutation is an alternative variant in close linkage disequilibrium with the ins44 variant, there is clear evidence that the age of onset of RPGRIP1-associated RD in this breed is influenced by a modifying locus, approximately 30 Mb away on chr15 (Miyadera et al. 2012b ) The purpose of this study was to identify the age modifying variant, with the aim of improving the understanding of RPGRIP1-associated RD.
Materials and methods
DNA was extracted from whole blood using the Nucleon BACC2 DNA extraction kit (GE Healthcare). DNA was extracted from buccal swabs using the QIAamp Midi kit (Qiagen).
Probes for target enrichment were designed using the design tool eArray with libraries prepared and sequenced at The Genome Analysis Centre, Norwich. The library for genome sequencing was prepared using the NEBNext Ultra DNA Library Prep Kit for Illumina, and sequencing performed on the Illumina MiSeq platform, generating an 82.5 Gb dataset of 300 bp paired-end reads. Alignment of reads to the reference genome CanFam3.1 was performed using BWA (Li and Durbin 2009) , and variants were called using GATK (McKenna et al. 2010) .
Screening of 23,040 clones of a canine BAC library (RPCI-81: Male Doberman Pinscher) was performed by qPCR of diluted cell lysates of glycerol stocks. Quantitative PCRs were carried out using KAPA Probe Fast qPCR ready mix on an ABI stepone plus real-time PCR machine. Positive BAC clones were streaked from glycerol stocks onto LB agar containing 12.5 mg/ml chloramphenicol and picked colonies grown in liquid LB containing 12.5 mg/ml chloramphenicol. BAC DNA was isolated using the ZR BAC DNA Miniprep Kit. Long PCRs were performed using KAPA HIFI Hot Start Ready Mix. Libraries for sequencing of BAC DNA and long PCR products on the Illumina MiSeq platform were prepared using the NEBNext Ultra DNA Library Prep Kit for Illumina. De novo assembly was performed using SOAPdenovo (Xie et al. 2014) .
RNA was extracted from spleen using the Qiagen RNeasy Midi Kit. Reverse transcription was performed using the Qiagen Quantitect reverse transcription kit. Expression analysis of MAP9 transcripts was performed using KAPA Probe Fast qPCR ready mix on an Illumina Eco qPCR machine. All primers are listed in Supplementary File 1.
Results
Target enriched massively parallel sequencing was used to generate sequence data for two EORD cases and eight controls (LORD cases), all of which were homozygous for the RPGRIP1 ins44 variant. The genomic target was the mapped interval for the age of onset modifying locus (chr15:51,980,056-53,979,789 CanFam3.1), with 82 % of the target region covered by at least two reads and 73 % of the target region achieved at least 209 coverage.
Sequence read alignments to the canine genome build CanFam3.1 identified 11,494 SNP and indel variants. Simple variants were filtered by how closely they segregated with disease status and consequence predictions. After filtering only one plausible variant remained, a SNP causing an amino acid substitution (S107Y) in the gene encoding cathepsin O (CTSO), which was predicted to be damaging through computational analysis using SIFT (Ng and Henikoff 2003) . By coincidence, this variant is included on the Illumina CanineSNP20 bead chip and had thus been genotyped in the cohort of MLHDs investigated by the genome-wide association study to map the modifying locus (ID: BICF2S2353161). Despite being the single SNP with the lowest associated p value (top SNP), the presence of several late onset individuals that were homozygous for the disease-associated CTSO variant meant that this variant could be excluded.
Further investigation of the modifying locus was carried out by visualising read alignments exon by exon and considering differences between EORD cases and controls (LORD cases). A region of zero read depth in EORD cases, but substantial read depth in controls, was identified across exon 9 of the gene encoding microtubule-associated protein 9 (MAP9) (Fig. 1) . The presence of a large number of reads aligning with a mapping quality of zero, which indicate more than one possible genomic coordinate for an alignment, suggested that the region was repetitive in nature. In addition, no reads were identified that spanned the region of zero read depth for early onset cases, which would usually indicate a deletion. The reads with a mapping quality of zero also aligned perfectly to chrUn_AAEX03022082, a 21 kb scaffold with no designated chromosome. A gene with high sequence similarity to MAP9 exon 8 through to exon 14, including introns, was present on chrUn_AAEX03022082. Short PCR across the region of zero read depth yielded products with no size difference between EORD and LORD cases due to the level of sequence similarity between the MAP9 region on chr15 and the MAP9-like region on chrUn_AAEX03022082. Although no capture probes were specifically designed to capture chrUn_AAEX03022082, the region was inadvertently captured due to the high levels of sequence similarity. In addition to the zero read depth shown for exon 9 of MAP9 on chr15 for EORD cases, no read alignments were seen for exons 11 through to 14 of the MAP9-like gene on chrUn_AAEX03022082. We sought to assemble chrUn_AAEX03022082 into the genome sequence to help determine the exact nature of the sequence variant identified.
In an attempt to determine the exact genomic assembly point for chrUn_AAEX03022082, screening of a canine BAC library (RPCI-81: Male Doberman Pinscher) was carried out to isolate clones containing chrUn_AAEX03022082. Two clones were identified, 36I10 and 40O5, for which BAC DNA was sequenced using a massively parallel approach. BAC ends were identified at coordinates chr15:52,766,756 and chr15:52,920,909 for isolate 40O5 indicating an assembly point within the chr15 MAP9 region. Sequencing data alignments for BAC isolate 36I10 identified BAC ends at chr15:52,778,639 and chrUn_AAEX03022082:3,729, identifying the chromosome 15 assembly point. De novo assembly of the BAC sequencing data was used to bridge the 5 0 assembly point between chr15 and ChrUn_AAEX03022082.
Although the 5 0 assembly position had been determined through BAC sequencing, further PCR-based investigation was required to determine the 3 0 assembly point. Alignment of chrUn_AAEX03022082 to chr15 using BLAST identified two regions only present on chromosome 15 that had no similarity to chrUn_AAEX03022082, allowing specific long PCR spanning from chr15 into chrUn_AAEX03022082 across the 3 0 assembly point (Fig. 2 ). Sequencing and de novo assembly of the long PCR product enabled the new assembly of chromosome 15 containing chrUn_AAEX03022082 to be completed. The assembly point for chrUn_AAEX03022082 was chr15:52,909,237 with a new end point of 52,930,899. Bases 1-74 of chrUn_ AAEX03022082 (part of MAP9 exon 8) were corrected as part of the assembly process. A novel 280 bp sequence was added after chrUn_AAEX03022082 (chr15:52,930, 899-52,931,179). We have given the new genome assembly the nominal title of CanFam3.1 MAP9_corrected .
The new assembly shows that the MAP9-like exons, which were previously part of chrUn_AAEX03022082, actually form the 3 0 region of the MAP9 gene. The 3 0 region of MAP9 on the previous assembly (exons [8] [9] [10] [11] [12] [13] [14] is the result of a partial duplication of the MAP9 gene and is a MAP9 pseudogene. Review of the BLAST results suggests exon 6 and 7 were part of the duplicated region but have subsequently been deleted. Alignment of genome data generated for an EORD case and target enrichment data from EORD cases and controls to the newly assembled CanFam3.1 MAP9_corrected was suggestive of a deletion in EORD cases potentially through homologous recombination. The deletion was confirmed in EORD cases and not LORD cases by long PCR to produce a product spanning the deletion joins. A PCR specific to the deleted region yielded products only for LORD cases (Fig. 3) . Definition of the deletion breakpoints could only Fig. 1 Area of zero read depth in target enrichment sequence data for EORD cases. Alignment of target enrichment sequence read data against the CanFam3.1 reference sequence revealed a region of zero read depth for EORD cases, but not for controls (LORD cases). The presence of a large number of reads in the region with zero mapping quality, suggested a region(s) of very high sequence similarity existed elsewhere in the genome. No paired alignments with greater than expected insert size were present, usually indicative of a deletion Fig. 2 BLAST results of chrUn_AAEX03022082 to chromosome 15. Alignment of the chrUn_AAEX03022082 sequence a against chromosome 15 b using BLAST revealed two regions which were specific to chromosome 15 (marked with asterisks). Corresponding alignment blocks are number from 1 to 12 and coloured from red through to blue, respectively. An apparent sequence join was identified on chrUn_AAEX03022082 (marked with a green dashed line), suggestive of a structural rearrangement event (Color figure online) be defined to be within a 1666 bp region through visualising alignments of targeted enrichment and genome data due to low read mapping quality and spurious alignments (Supplementary File 2) . Although precise and certain definition of the deletion breakpoint was impossible due to the level of sequence similarity between the two genes, a minimal deletion join/breakpoint region of 231 bp was identified using multiple sequence alignment of de novo assembled reads generated from the PCR product spanning the deletion (Supplementary File 3) . The 5 0 region of the join showed sequence similarity to the region upstream of the 5 0 deletion breakpoint and the 3 0 region of the join showed sequence similarity to region downstream of the 3 0 deletion breakpoint. The size of deletion based on new genome build CanFam3.1 MAP9_corrected is 21,961 bp, with deletion breakpoints in intron 10 of MAP9 and MAP9 pseudogene [chr15:52,905,335-52,905,565 and chr15:52, 927,296-52,927,527 (chrUn_AAEX03022082:3379-3609)]. The new genome arrangement with key coordinates is shown graphically in Fig. 4 , and a timeline of chromosome 15 rearrangement events is summarised in Fig. 5 .
Despite the deletion, the joining of MAP9 with the MAP9-like pseudogene appears to produce a complete MAP9 reading frame which we have termed MAP9 EORD . Sequencing of cDNA from spleen of an EORD case (used as retina tissue was unavailable) confirmed that a full length product and in frame transcript was produced from the MAP9 EORD gene. A number of residue changes were identified between the canine MAP9 EORD and canine MAP9 transcripts. Multiple sequence alignment was performed alongside human MAP9, and vertebrate species conservation was considered for variant residues (Supplementary file 4). The PolyPhen tool was used to predict whether the variants could alter protein function. The variant N555K was private to EORD cases on consideration of vertebrate species alignments and was predicted by PolyPhen to be probably deleterious. The variant N579S was also predicted by PolyPhen to be probably deleterious and is a highly conserved residue across species. The deleted residue E584 is also highly conserved amongst vertebrate species.
Association of MAP9 EORD with the EORD phenotype was investigated by genotyping a subset of the EORD and LORD cases used for mapping of the early onset locus. The arbitrary age boundary for EORD cases was set at 5 years of age, and LORD cases were defined as diagnosed with RD at [5 years of age. In total, there were 32 EORD cases and 18 LORD cases. Of the 30 EORD cases that genotyped successfully 26 were homozygous for MAP9 EORD and for the LORD cases, one was homozygous for MAP9 EORD (Table 1 ). The LORD case, which was homozygous for MAP9 EORD had an age of diagnosis of 5.2 years of age, i.e. close to the arbitrary cutoff, and quite likely to have had an onset age below 5 years. In addition, the sample set was genotyped for the top SNP from the age of onset locus genome-wide association study. Allelic association analysis performed on the top SNP and the MAP9 EORD genotypes gave p values of 1.4 9 10 -5 and 4.0 9 10 -8 , respectively. A full description of results is show in Supplementary File 5.
The gene duplication, which is present in the canine reference sequence (Boxer) and the MLHD, was investigated in 96 dogs of 32 other breeds, by specific qPCR across the duplication join (i.e. within the MAP9 deletion region). Three dogs of each of the following breeds were investigated: American Cocker Spaniel, Australian Shepherd, Boxer, Border Collie, Brittany Spaniel, Chesapeake Bay retriever, Cocker Spaniel, Doberman, English Springer Spaniel, Flat Coated Retriever, Field Spaniel, Grand Basset Griffon Vendeen, Great Dane, Golden Retriever, Giant Schnauzer, Hovawarts, Irish setter, Italian Spinone, Lancashire Heeler, Labrador Retriever, Miniature Bull Terrier, Miniature Poodle, Otterhound, Staffordshire Bull Terrier, Scottish Deerhounds, Soft-coated Wheaten Terrier, Standard Poodle, Shetland Sheepdogs, Tibetan Spaniel, Tibetan Terrier, West Highland White Terrier and Welsh Springer Spaniel. Deletion alleles were identified in two individuals of two breeds, the Tibetan Terrier and Brittany. These alleles were further investigated using long PCR followed by massively parallel sequencing. Read alignment patterns and SNP analysis suggested a novel deletion event had occurred in the Tibetan Spaniel. The Brittany deletion showed high similarity to the deletion identified for the MLHD (Supplementary File 6) . Genome comparison by BLAST suggests that the duplication is not present in the Fig. 3 MAP9 EORD genotyping PCR. Genotyping of MAP9 EORD was carried out by performing one long PCR across the deletion breakpoints and a specific PCR within the deleted region. PCR products were pooled before running on an agarose gel. Lanes 2-4 show a single band representing a PCR product crossing the deletion join (All EORD cases). Lanes 5-6 show a single band representing the PCR within the deleted region. Lane 7 is a heterozygous individual cat, the phylogenetically most similar genome sequence to the dog available.
To determine the frequency of the MAP9 EORD allele within the Miniature Dachshund (MD) and ESS populations, 640 MDs (202 long haired, 348 smooth haired and 90 wire haired) and 206 ESSs were genotyped. Two MLHDs were homozygous for MAP9 EORD (one ins44 homozygote and one ins44 heterozygote). A carrier frequency of 17.92 % for the MLHD population was calculated assuming Hardy-Weinberg equilibrium (q = 0.0995). No MAP9 EORD homozygotes were identified in the ESSs sample set.
Discussion
Cone-rod RD in the MLHD is an example of a canine disease that segregates as a seemingly early onset recessive trait in an inbred population but manifests differently within a wider population albeit of the same breed. In this investigation, we built on a previous age of onset locus mapping study, by using target enrichment data to identify a genomic deletion across MAP9 as the potential age of onset modifying mutation.
The primary defect in the cone-rod degeneration in a colony of MLHDs is known to be in RPGRIP1, caused by either or both of a polyA tract insertion in exon 2 of the gene (Mellersh et al. 2006 ) and a mutation elsewhere in the same confidence interval (Kuznetsova et al. 2012) . The RPGRIP1 mutation is leaky (Miyadera et al. 2012a , Miyadera et al. 2009 ) and gives rise to LORD or no clinically significant phenotype in the absence of a second homozygous mutation segregating in the interval containing MAP9 (Miyadera et al. 2012b ). Here we have shown that RPGRIP1 ins44/ins44 dogs with EORD have several polymorphisms in MAP9, some of them potentially harmful, when compared with MAP9 in LORD dogs. We hypothesise that this reflects a partial deficit in MAP9 protein function in the retina. This finding adds to a growing number of examples of modifiers affecting the RD phenotype mostly in mice models as well as in humans (Khanna et al. 2009; Maddox et al. 2012; Markand et al. 2015; Schon et al. 2016; Venturini et al. 2012; Vollrath et al. 2015) . MAP9, also known as ASAP (aster-associated protein), is associated with microtubules in interphase, with the mitotic spindle at mitosis, and with the centrosome during cytokinesis. It binds directly to pre-polymerised a-tubulin microtubules in vitro through its C-terminal domain, and co-sediments with cellular microtubules ex vivo (Saffin et al. 2005) . Phosphorylation of MAP9 at serine 625 (human, 626 in dog) by Aurora A kinase is essential for correct assembly onto centrosomes and for mitotic progression (Venoux et al. 2008 ). This residue is preserved in both the MAP9 proteins described here. MAP9 is probably expressed in all cell types, but shows high level expression in testes, brain, eye, spinal cord, fertilised ovum and intermediate expression in kidney, heart, lung and a small number of other tissues. Within the eye, expression is known to be high in the retina, at least in the zebrafish (Saffin et al. 2005 ). Expression has not been mapped at this level in other species. In non-dividing cells such as photoreceptors, the centrosome contributes a centriole to form the basal body of the primary cilium. Although not proven, it is likely that MAP9 remains associated with the a-tubulin in the basal body and MAP9 has been associated with the cytoskeletal component of the murine photoreceptor cilium (Liu et al. 2007) , whilst in zebra fish, eye development is especially sensitive to morpholino driven reduction in MAP9 availability (Fontenille et al. 2014) . RPGRIP1 is also known to locate to the ciliary axoneme, where it is closely associated with RPGR, and appears to act as a ciliary targeting protein for RPGR, NPHP4 and SDCCAG8 (Boylan and Wright 2000; Hong et al. 2001; Patil et al. 2012; Roepman et al. 2005; Shu et al. 2005; Zhao et al. 2003) mutations in each of which cause a different retinal degeneration in dogs or other species. These degenerations have all been commonly described as ciliopathies. RPGRIP1 mutations have profound effects on the stability and maintenance of the connecting cilium and its ability to support outer segment morphogenesis (e.g. Zhao et al. 2003) . Changes in the cilium in RPGRIP1 -animals include reductions in acetylated a-tubulin in the axoneme in photoreceptors (Patil et al. 2012) . Hence, a MAP9 partial deficit is a particularly attractive candidate to synergise with a partial RPGRIP1 deficit to cause a more serious disease. It is notable that MAP9 is highly expressed in spermatogonia and in spermatocytes (Saffin et al. 2005) . It is tempting to speculate that the original colony of cord1 (EORD) MLHD, in which low fertility was a persistent problem (Debra Flack, personal communication) and the EORD haplotype at MAP9 was fixed, may have been showing a syndromic effect of the MAP9 mutation described here. On the other hand, up to one-third of all retinopathies are non-syndromic ciliary defects even though many of the mutated genes are expressed widely outside the eye (Estrada-Cuzcano et al. 2012) .
Identification of the MAP9 deletion was facilitated by correction of the canine genome build CanFam3.1. In the new assembly, which we have given the nominal title CanFam3.1 MAP9_corrected, there is evidence of a historic partial duplication of MAP9 through a hypothesised homologous recombination event. The tandem repeat structure explains the difficulty in assembling this region for the CanFam3.1 genome build. A subsequence deletion event, which again is likely to have occurred through homologous recombination, gives rise to a fusion of two halves of the partially duplicated MAP9 gene to give a new gene, MAP9 EORD , which is strongly associated with the EORD phenotype. Investigation of other breeds for this variant identified individuals of two breeds, the Tibetan Terrier and Brittany Spaniel, with a similar gene arrangement to MAP EORD . Haplotype analysis of these breeds showed that at least one of the deletion events appeared novel, further highlighting the region's vulnerability to rearrangement (Supplementary File 6). From our available clinical data there appears to be no phenotype associated solely with MAP9 EORD although formal investigation would be required to rule this possibility out.
Although the CanFam3.1 genome build is largely complete, there are still 15 unplaced scaffolds (unattached scaffolds, which are not assigned to a chromosomal location) and 223 unlocalised scaffolds, for which the chromosome is known, but the position and orientation is not. As many of these scaffolds are likely to contain very repetitive regions of the genome, it is likely that further improvement to the genome build will require the use of ultra-long read sequencing technology. Analysing short massively parallel sequence read alignments across repetitive regions is challenging. Although sequence reads may be accurate, a single variant in the reference sequence can result in reads aligning to an alternative region, leading to a gap in coverage and potentially falsely indicating a deletion. The opposite may also be also be true, where a deletion may be present but if reads map equally to both the deleted region and an alternative region, then the deleted region could be masked to some extent by reads of mapping quality zero. Both of these factors made detection of the deletion region and determination of the likely deletion breakpoints challenging.
Diagnostic DNA testing, which is commonly used in the dog, for MAP9 EORD is challenging as a short PCR-based assay is difficult to develop due to the unavailability of specific priming sites and long range PCR techniques may lack sensitivity, especially for DNA samples extracted from buccal swabs. Detection of presence or absence of MAP EORD by qPCR can be used to specify early onset or late onset status for ins44 homozygotes, however, and also enables MAP EORD allele frequency estimates. Our data suggest MAP9 EORD frequency is low in the MD population, implying that the majority of RPGRIP1 ins44 dogs are not likely to have the EORD phenotype. No MAP9 EORD alleles were detected in the ESS sample set. Although a larger sample set would be required to rule out the presence of MAP9 EORD , the result suggests that early onset retinal degeneration in the ESS is due to an alternative modifier or a separate genetic or clinical cause.
To summarise, we have identified a deletion across the tandemly duplicated MAP9 gene in the canine genome which segregates closely with EORD in the MLHD. Although a full MAP9 open reading frame is maintained, the deletion results in the introduction of a number of variants which are predicted to be deleterious. This is a consequence of the 3 0 region being formed from a redundant MAP9 partial pseudogene. We speculate that the interaction between MAP9 and RPGRIP1 are important in the function of the retina, and disruption of MAP9 in the context of RPGRIP1 ins44 mutation homozygosity results in the EORD phenotype.
Using different inbred populations of dog, we have been able to tease apart the genetic basis of an inherited trait with a variable age of onset and demonstrate the interaction of two independent loci that contribute to the phenotype. The variation in age of onset between populations is explained by the fact that one of the populations was fixed for the modifier locus so the trait effectively segregated as a simple Mendelian trait in that population, an important consideration for the study of recessive conditions with small sample sets from closed or restricted populations.
